572735

Lupin Pharmaceuticals Inc. — FEI 3004097115

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 27, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Naples, FL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)